134 related articles for article (PubMed ID: 2314116)
1. Monoclonal antibody B-ly7: a sensitive marker for detection of minimal residual disease in hairy cell leukemia.
Thaler J; Dietze O; Faber V; Greil R; Gastl G; Denz H; Ho AD; Huber H
Leukemia; 1990 Mar; 4(3):170-6. PubMed ID: 2314116
[TBL] [Abstract][Full Text] [Related]
2. Immunohistological assessment of bone marrow biopsies from patients with hairy cell leukemia: changes following treatment with alpha-2-interferon and deoxycoformycin.
Thaler J; Denz H; Dietze O; Gastl G; Ho AD; Gattringer C; Greil R; Lechleitner M; Huber C; Huber H
Leuk Res; 1989; 13(5):377-83. PubMed ID: 2787447
[TBL] [Abstract][Full Text] [Related]
3. Flow cytometry of peripheral blood and bone marrow cells from patients with hairy cell leukemia: phenotype of hairy cells, lymphocyte subsets and detection of minimal residual disease after treatment.
Babuŝíková O; Tomová A; Kusenda J; Gyárfás J
Neoplasma; 2001; 48(5):350-7. PubMed ID: 11845978
[TBL] [Abstract][Full Text] [Related]
4. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
[TBL] [Abstract][Full Text] [Related]
5. Minimal residual disease in hairy-cell leukemia after treatment with 2-chlorodeoxyadenosine.
Konwalinka G; Schirmer M; Hilbe W; Fend F; Geisen F; Knoblechner A; Petzer A; Thaler J
Blood Cells Mol Dis; 1995; 21(2):142-51. PubMed ID: 8846043
[TBL] [Abstract][Full Text] [Related]
6. Selection of a panel of monoclonal antibodies for monitoring residual disease in peripheral blood and bone marrow of interferon-treated hairy cell leukaemia patients.
Falini B; Pileri SA; Flenghi L; Liberati M; Stein H; Gerli R; Minelli O; Martelli MF; Lauria F; Poggi S
Br J Haematol; 1990 Dec; 76(4):460-8. PubMed ID: 1702309
[TBL] [Abstract][Full Text] [Related]
7. Long-term follow-up of patients with hairy cell leukaemia treated with pentostatin: lymphocyte subpopulations and residual bone marrow infiltration.
Thaler J; Grünewald K; Gattringer C; Ho AD; Weyrer K; Dietze O; Stauder R; Fluckinger T; Lang A; Huber H
Br J Haematol; 1993 May; 84(1):75-82. PubMed ID: 8338781
[TBL] [Abstract][Full Text] [Related]
8. [Results of treatment in patients with hairy cell leukemia with splenectomy, alpha-interferon and deoxycoformycin].
Gotić M; Rolović Z; Radosević N; Draguljac N; Jovanović V; Bogdanović A; Bosković D
Srp Arh Celok Lek; 2000; 128(7-8):262-70. PubMed ID: 11089434
[TBL] [Abstract][Full Text] [Related]
9. Hairy cell leukemia: a model for studying the B cell family of diseases.
Al-Katib A; Berman E; Black P; Koziner B
Semin Oncol; 1986 Dec; 13(4 Suppl 5):48-54. PubMed ID: 3492047
[TBL] [Abstract][Full Text] [Related]
10. A novel CD11c monoclonal antibody effective in formalin-fixed tissue for the diagnosis of hairy cell leukemia.
Johrens K; Happerfield LC; Brown JP; Erber WN; Stein H; Anagnostopoulos I
Pathobiology; 2008; 75(4):252-6. PubMed ID: 18580071
[TBL] [Abstract][Full Text] [Related]
11. The diagnostic value of CD123 in B-cell disorders with hairy or villous lymphocytes.
Del Giudice I; Matutes E; Morilla R; Morilla A; Owusu-Ankomah K; Rafiq F; A'Hern R; Delgado J; Bazerbashi MB; Catovsky D
Haematologica; 2004 Mar; 89(3):303-8. PubMed ID: 15020268
[TBL] [Abstract][Full Text] [Related]
12. T-bet transcription factor detection facilitates the diagnosis of minimal hairy cell leukemia infiltrates in bone marrow trephines.
Jöhrens K; Stein H; Anagnostopoulos I
Am J Surg Pathol; 2007 Aug; 31(8):1181-5. PubMed ID: 17667540
[TBL] [Abstract][Full Text] [Related]
13. The beneficial effects of alpha-interferon in hairy cell leukemia are not attributable to NK cell-mediated cytotoxicity.
Griffiths SD; Cawley JC
Leukemia; 1987 Apr; 1(4):372-6. PubMed ID: 3669763
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis and monitoring in patients with hairy cell leukemia using the monoclonal antibody anti-HC2.
Berman E; Posnett DN
Leukemia; 1987 Apr; 1(4):305-7. PubMed ID: 3669750
[TBL] [Abstract][Full Text] [Related]
15. Assessment of bone marrow infiltration by magnetic resonance imaging in patients with hairy cell leukemia treated with pentostatin or alpha-interferon.
Bentz M; Döhner H; Gückel F; Semmler W; Kauczor HU; van Kaick G; Ho AD; Hunstein W
Leukemia; 1991 Oct; 5(10):905-7. PubMed ID: 1961024
[TBL] [Abstract][Full Text] [Related]
16. Magnetic resonance imaging of bone marrow in hairy cell leukemia: correlation with clinical response to alpha-interferon.
Thompson JA; Shields AF; Porter BA; Olson DO; Rubin E; Kidd P; Fefer A
Leukemia; 1987 Apr; 1(4):315-6. PubMed ID: 3669752
[TBL] [Abstract][Full Text] [Related]
17. Changes in peripheral blood and bone marrow specimens during and after alpha 2b-interferon therapy for hairy cell leukemia.
Bardawil RG; Ratain MJ; Golomb HM; Bitter MA; Groves C; Vardiman JW
Leukemia; 1987 Apr; 1(4):340-3. PubMed ID: 3669760
[TBL] [Abstract][Full Text] [Related]
18. B-cell growth factor-induced and alpha-interferon-inhibited proliferation of hairy cells coincides with modulation of cell surface antigens.
Gamliel H; Brownstein BH; Gurfel D; Wu SH; Rosner MC; Golomb HM
Cancer Res; 1990 Jul; 50(13):4111-20. PubMed ID: 2354460
[TBL] [Abstract][Full Text] [Related]
19. Relationship between hairy cell leukemia variant and splenic lymphoma with villous lymphocytes: presentation of a new concept.
Sun T; Dittmar K; Koduru P; Susin M; Teichberg S; Brody J
Am J Hematol; 1996 Apr; 51(4):282-8. PubMed ID: 8602628
[TBL] [Abstract][Full Text] [Related]
20. Hairy-cell leukemia. Morphologic, cytochemical, and immunologic features.
Paoletti M; Bitter MA; Vardiman JW
Clin Lab Med; 1988 Mar; 8(1):179-95. PubMed ID: 3282758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
